6:33 AM
samizares
Scientists have developed a new ten times cheaper ultra-sensitive
sensor test to detect the early stages of several cancers and viruses,
including HIV, with the naked eye.Researchers from the Imperial College London claim that their
visual sensor technology is ten times more sensitive than the current
gold standard methods for measuring biomarkers.
These indicate the onset of diseases such as prostate cancer and
infection by viruses including HIV. The colour of a liquid changes to
give either a positive or negative result.Researchers say their sensor would benefit countries where
sophisticated detection equipment is scarce, enabling cheaper and
simpler detection and treatments for patients.
The team tested the effectiveness of the sensor by detecting a
biomarker called p24 in blood samples, which indicates HIV infection."Unfortunately, the existing gold standard detection methods can
be too expensive to be implemented in parts of the world where resources
are scarce," Professor Molly Stevens, from the Departments of Materials
and Bioengineering, said.
"Our approach affords for improved sensitivity, does not require
sophisticated instrumentation and it is ten times cheaper, which could
allow more tests to be performed for better screening of many diseases,"
said Stevens.Researchers also tested samples for the biomarker called Prostate
Specific Antigen (PSA), which is an early indicator for Prostate
Cancer. The team say the sensor can also be reconfigured for other
viruses and diseases where the specific biomarker is known.
The sensor works by analysing serum, derived from blood, in a
disposable container. If the result is positive for p24 or PSA, there is
a reaction that generates irregular clumps of nanoparticles, which give
off a distinctive blue hue in a solution inside the container.
Powered by Twitter Fan Box & Pizcar
Posted in: HIV and Cancer detection
